Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk

IMPORTANCE: Allergic reactions among some individuals who received the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine discourage patients with allergic conditions from receiving this vaccine and physicians from recommending the vaccine. OBJECTIVE: To describe the assessment and immunization of highly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shavit, Ronen, Maoz-Segal, Ramit, Iancovici-Kidon, Mona, Offengenden, Irena, Haj Yahia, Soad, Machnes Maayan, Diti, Lifshitz-Tunitsky, Yulia, Niznik, Stanley, Frizinsky, Shirly, Deutch, Michal, Elbaz, Eti, Genaim, Hosney, Rahav, Galia, Levy, Itzchak, Belkin, Anna, Regev-Yochay, Gili, Afek, Arnon, Agmon-Levin, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408666/
https://www.ncbi.nlm.nih.gov/pubmed/34463744
http://dx.doi.org/10.1001/jamanetworkopen.2021.22255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408666/
https://www.ncbi.nlm.nih.gov/pubmed/34463744
http://dx.doi.org/10.1001/jamanetworkopen.2021.22255

Ejemplares similares